METHOD OF CONTINUOUS PRODUCTION OF RETROVIRUSES (HTL V-III) FROM PATIENTS WITH AIDS AND PRE-AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


METHOD OF CONTINUOUS PRODUCTION OF RETROVIRUSES (HTL V-III) FROM PATIENTS WITH AIDS AND PRE-AIDS.

Available from National Technical Information Service, Springfield, VA as NTIS/NTN84-0398, 1p 1984. Unique Identifier : AIDSLINE ICDB/85609420
Department of Health and Human Services; Washington, DC.

Abstract: This citation summarizes a one-page announcement of technology available for utilization. A cell system is disclosed for the reproducible detection and isolation of human T-lymphotropic retroviruses (HTLV-family) with cytopathic effects (HTLV-III) from patients with acquired immune deficiency syndrome (AIDS), pre-AIDS and in healthy carriers. One neoplastic aneuploid T-cell line derived from an adult with lymphoid leukemia, and termed HT, was susceptible to infection with the new variants of HTLV, which are transformed and providing T-cell populations which are highly susceptible and permissive for HTLV-III, and convenience for large scale production, isolation, and biological detection of the virus. Please contact Mr. George Kudravetz or a staff member of the Office of Federal Patent Licensing for additional information. Refer to: PAT-APPL-6,602,946. Office of Federal Patent Licensing, National Technical Information Service, Room 9R, Springfield, Va. 22161. (Author abstract)
Keywords: Acquired Immunodeficiency Syndrome/*MICROBIOLOGY Adult Human HTLV-BLV Viruses/*ISOLATION & PURIF Virus Cultivation/METHODS GOVERNMENT REPORT

KWDacquiredimmunodeficiencysyndrome/KWDmicrobiologyadulthumanhtlv-blvviruses/KWDisolation&purifviruscultivation/methodsgovernmentreport
850630
M8560165

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .